FOXO4-DRI Potential Selectivity As mentioned, FOXO4-DRI is believed to selectively disrupt the binding of FOXO4 to p53, which may lead to the activation of p53, which in turn may stimulate the process of removing senescent cells
Therefore, the medical use of glutathione for this purpose is not common in many countries
Moreover, TG2 mediates HPV-E7 and eIF4E-BP polyamination, which affects their respective interactions with Rb and Raptor to suppress HPV-E7 and selectively control translation 7,8
Ichida, S., Yuzawa, Y., Okada, H., Yoshioka, K
How we measure success after treatment We score outcomes against three measures: the patients own goal as stated at consult, the photograph difference under standardized lighting at 14 days (injectables) or 90 days (energy work), and validated clinical scales (Merz Aesthetic Scale, Allergan FACE-Q, Fitzpatrick Wrinkle Scale, Goldberg Scar Scale) where applicable